Stem cell therapy: a novel frontier in the treatment of liver fibrosis/cirrhosis
Open Access
- 28 November 2025
- journal article
- review article
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 17 (1)
Abstract
Liver fibrosis and cirrhosis are characterized by the excessive accumulation of extracellular matrix (ECM) in the liver, and they represent significant gloKeywords
This publication has 114 references indexed in Scilit:
- Human Umbilical Cord Blood-Derived Mesenchymal Stem Cell Transplantation for Patients with Decompensated Liver CirrhosisJournal of Gastrointestinal Surgery, 2023
- CRISPR/Cas9–Mediated Gene Knockout and Knockin Human iPSCs2020
- Mechanistic Basis of ex Vivo Umbilical Cord Blood Stem Progenitor Cell ExpansionStem Cell Reviews and Reports, 2020
- Liver diseases in the dish: iPSC and organoids as a new approach to modeling liver diseasesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2019
- Validation of Current Good Manufacturing Practice Compliant Human Pluripotent Stem Cell-Derived Hepatocytes for Cell-Based TherapyStem Cells Translational Medicine, 2018
- Hepatocyte-like cells derived from induced pluripotent stem cellsHepatology International, 2016
- Phase II Trial: Undifferentiated Versus Differentiated Autologous Mesenchymal Stem Cells Transplantation in Egyptian Patients with HCV Induced Liver CirrhosisStem Cell Reviews and Reports, 2011
- Highly Efficient Generation of Human Hepatocyte–Like Cells From Induced Pluripotent Stem CellsHepatology, 2009
- Expression of drug metabolizing enzymes in hepatocyte-like cells derived from human embryonic stem cellsBiochemical Pharmacology, 2007
- Directed differentiation of human embryonic stem cells into functional hepatic cells†Hepatology, 2007